IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 1 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 2,274 | -76.8% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 9,822 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -96.0% | 9,822 | -95.3% | 0.00% | – |
| Q1 2021 | $274,000 | +2640.0% | 211,158 | +7262.6% | 0.00% | – |
| Q4 2020 | $10,000 | – | 2,868 | +6895.1% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 41 | -96.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 1,051 | +3.1% | 0.00% | – |
| Q1 2020 | $1,000 | -90.9% | 1,019 | -75.7% | 0.00% | – |
| Q2 2019 | $11,000 | 0.0% | 4,202 | -9.5% | 0.00% | – |
| Q1 2019 | $11,000 | – | 4,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |